In this episode of The Lead, host Tina Baykaner, MD, MPH, is joined by Christopher Kowalewski, MD, and Marco Perez, MD, to discuss the journal article, Atrial Fibrillation Screening According to Genetic Risk: A Secondary Analysis of the Randomized LOOP Study. Together, they review findings from this secondary analysis of the LOOP Study and explore the relationship between genetic risk and atrial fibrillation screening.
Learning Objectives
- Review the key findings from the secondary analysis of the randomized LOOP Study examining atrial fibrillation screening according to genetic risk.
- Discuss the relationship between genetic risk and atrial fibrillation screening as evaluated in the study.
- Explore the potential implications of incorporating genetic risk into atrial fibrillation screening strategies.
Host: Tina Baykaner, MD, MPH
Guests: Christopher Kowalewski, MD and Marco Perez, MD
Disclosures:
T. Baykaner
- Honoraria/Speaking/Consulting Fee: Volta Medical, Medtronic, Pacemate, Johnson & Johnson, Abbott Medical, Boston Scientific
- Research: NIH, Boston Scientific
C. Kowalewski
M. Perez
- Ownership/Partnership/Principal: QALY
- Honoraria/Speaking/Consulting Fee: Boston Scientific, Biotronik
- Research: Apple, Inc.
- Other/Stock Options Privately Held
